molecular function |
| GO:0035612 | | AP-2 adaptor complex binding | | Interacting selectively and non-covalently with the AP-2 adaptor complex. The AP-2 adaptor complex is a heterotetrameric AP-type membrane coat adaptor complex that consists of alpha, beta2, mu2 and sigma2 subunits and links clathrin to the membrane surface of a vesicle. In at least humans, the AP-2 complex can be heterogeneric due to the existence of multiple subunit isoforms encoded by different alpha genes (alphaA and alphaC). |
| GO:0005096 | | GTPase activator activity | | Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP. |
| GO:0031896 | | V2 vasopressin receptor binding | | Interacting selectively and non-covalently with a V2 vasopressin receptor. |
| GO:0031691 | | alpha-1A adrenergic receptor binding | | Interacting selectively and non-covalently with an alpha-1A adrenergic receptor. |
| GO:0031692 | | alpha-1B adrenergic receptor binding | | Interacting selectively and non-covalently with an alpha-1B adrenergic receptor. |
| GO:0031701 | | angiotensin receptor binding | | Interacting selectively and non-covalently with an angiotensin receptor. |
| GO:0035615 | | clathrin adaptor activity | | The binding activity of a molecule that brings together clathrin and one or more other molecules, permitting them to function in a coordinated way. |
| GO:0043027 | | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | | Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
| GO:0004857 | | enzyme inhibitor activity | | Binds to and stops, prevents or reduces the activity of an enzyme. |
| GO:0030331 | | estrogen receptor binding | | Interacting selectively and non-covalently with an estrogen receptor. |
| GO:0031762 | | follicle-stimulating hormone receptor binding | | Interacting selectively and non-covalently with a follicle-stimulating hormone receptor. |
| GO:0004402 | | histone acetyltransferase activity | | Catalysis of the reaction: acetyl-CoA + histone = CoA + acetyl-histone. |
| GO:0005159 | | insulin-like growth factor receptor binding | | Interacting selectively and non-covalently with the insulin-like growth factor receptor. |
| GO:0044325 | | ion channel binding | | Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. |
| GO:0031434 | | mitogen-activated protein kinase kinase binding | | Interacting selectively and non-covalently with a mitogen-activated protein kinase kinase, any protein that can phosphorylate a MAP kinase. |
| GO:0051219 | | phosphoprotein binding | | Interacting selectively and non-covalently with a phosphorylated protein. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0045309 | | protein phosphorylated amino acid binding | | Interacting selectively and non-covalently with a phosphorylated amino acid residue within a protein. |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| GO:0044212 | | transcription regulatory region DNA binding | | Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
| GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
biological process |
| GO:0002031 | | G-protein coupled receptor internalization | | The process that results in the uptake of a G-protein coupled receptor into an endocytic vesicle. |
| GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| GO:0006897 | | endocytosis | | A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle. |
| GO:0042699 | | follicle-stimulating hormone signaling pathway | | The series of molecular signals mediated by follicle-stimulating hormone. |
| GO:0070373 | | negative regulation of ERK1 and ERK2 cascade | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:0034260 | | negative regulation of GTPase activity | | Any process that stops or reduces the rate of GTP hydrolysis by a GTPase. |
| GO:0032088 | | negative regulation of NF-kappaB transcription factor activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
| GO:0043154 | | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. |
| GO:0032715 | | negative regulation of interleukin-6 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production. |
| GO:0032717 | | negative regulation of interleukin-8 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-8 production. |
| GO:0001933 | | negative regulation of protein phosphorylation | | Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein. |
| GO:0031397 | | negative regulation of protein ubiquitination | | Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| GO:0009968 | | negative regulation of signal transduction | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction. |
| GO:0007602 | | phototransduction | | The sequence of reactions within a cell required to convert absorbed photons into a molecular signal. |
| GO:0030168 | | platelet activation | | A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. |
| GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:0043547 | | positive regulation of GTPase activity | | Any process that activates or increases the activity of a GTPase. |
| GO:0035025 | | positive regulation of Rho protein signal transduction | | Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction. |
| GO:0043280 | | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
| GO:0090240 | | positive regulation of histone H4 acetylation | | Any process that increases the rate, frequency, or extent of histone H4 acetylation, the modification of histone H4 by the addition of an acetyl group. |
| GO:0035066 | | positive regulation of histone acetylation | | Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein. |
| GO:0035774 | | positive regulation of insulin secretion involved in cellular response to glucose stimulus | | Any process that increases the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose. |
| GO:0033138 | | positive regulation of peptidyl-serine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| GO:0032092 | | positive regulation of protein binding | | Any process that activates or increases the frequency, rate or extent of protein binding. |
| GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| GO:0031398 | | positive regulation of protein ubiquitination | | Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| GO:0002092 | | positive regulation of receptor internalization | | Any process that activates or increases the frequency, rate or extent of receptor internalization. |
| GO:0034393 | | positive regulation of smooth muscle cell apoptotic process | | Any process that activates or increases the frequency, rate, or extent of smooth muscle cell apoptotic process. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0043161 | | proteasome-mediated ubiquitin-dependent protein catabolic process | | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| GO:0015031 | | protein transport | | The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| GO:0016567 | | protein ubiquitination | | The process in which one or more ubiquitin groups are added to a protein. |
| GO:0008277 | | regulation of G-protein coupled receptor protein signaling pathway | | Any process that modulates the frequency, rate or extent of G-protein coupled receptor protein signaling pathway activity. |
| GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0036276 | | response to antidepressant | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antidepressant stimulus, a mood-stimulating drug. |
| GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| GO:0043149 | | stress fiber assembly | | The aggregation, arrangement and bonding together of a set of components to form a stress fiber. A stress fiber is a contractile actin filament bundle that consists of short actin filaments with alternating polarity. |
| GO:0006366 | | transcription from RNA polymerase II promoter | | The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
| GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
| GO:0006810 | | transport | | The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein. |
cellular component |
| GO:0000139 | | Golgi membrane | | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| GO:0016323 | | basolateral plasma membrane | | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
| GO:0042995 | | cell projection | | A prolongation or process extending from a cell, e.g. a flagellum or axon. |
| GO:0000785 | | chromatin | | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
| GO:0005905 | | clathrin-coated pit | | A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0031410 | | cytoplasmic vesicle | | A vesicle found in the cytoplasm of a cell. |
| GO:0030659 | | cytoplasmic vesicle membrane | | The lipid bilayer surrounding a cytoplasmic vesicle. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0043197 | | dendritic spine | | A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including "thin", "stubby", "mushroom", and "branched", with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity. |
| GO:0005834 | | heterotrimeric G-protein complex | | Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G-protein coupled receptors to an effector protein. |
| GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| GO:0005765 | | lysosomal membrane | | The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| GO:0014069 | | postsynaptic density of dendrite | | An electron dense network of proteins within and adjacent to the postsynaptic membrane of the dendrite of asymetric synapses. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components. |
| GO:0045211 | | postsynaptic membrane | | A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. |
| GO:0031143 | | pseudopodium | | A temporary protrusion or retractile process of a cell, associated with flowing movements of the protoplasm, and serving for locomotion and feeding. |